Bryant Furlow

Bryant Furlow is medical journalist working at the crossroads of research, clinical practice, and public policy. His work has appeared The Lancet, New Scientist, and Oncology Nurse Advisor.

Most Recent Articles by Bryant Furlow

Squamous Cell Lung Cancer Cells Are Sugar-dependent

Squamous Cell Lung Cancer Cells Are Sugar-dependent

By

Squamous cell lung cancers, a form of NSCLC, are glucose-dependent, while adenocarcinoma NSCLC tumors are largely glucose-independent.

Lung Cancer Radiotherapy Might Improve Immune Checkpoint Blockade-associated Survival

Lung Cancer Radiotherapy Might Improve Immune Checkpoint Blockade-associated Survival

By

Researchers call for additional clinical trials investigating radiotherapy followed by immune checkpoint blockade for patients with NSCLC.

Green Tea and Cancer

Green Tea and Cancer

By

There is limited epidemiologic and lab-experiment evidence that green tea and green tea compounds are capable at high concentrations of affecting tumor biology.

HPV, p16 Status May Affect Prognosis in HNSCC

HPV, p16 Status May Affect Prognosis in HNSCC

By

Among patients suffering post-radiation or chemoradiation locoregional HNSCC recurrence, those with HPV-positive disease may have better survival rates.

FOLFOXIRI-Bev May Improve Surgical Resection Rate in Colorectal Cancer

FOLFOXIRI-Bev May Improve Surgical Resection Rate in Colorectal Cancer

By

FOLFOXIRI-Bev yields "rapid and deep cytoreduction" that can improve patients' opportunities for metastatic colorectal tumor resection.

More Articles by Bryant Furlow

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters